project id: TCGA-BRCA; case submitter id: TCGA-AO-A12G; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.1; spectrophotometer method: UV Spec; age at index: 75; days to birth: -27705; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 27705; ajcc pathologic m: M0; ajcc pathologic n: N0 (i+); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1639.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8022/3; primary diagnosis: Pleomorphic carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1415; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-AO-A12G-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent neutrophil infiltration: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;